2024 Here we go again., page-600

Yep.

Approval should be by December at the latest.

Following year.... I assume they will get massive penetration, because they will be the only approved treatment. say 80% if we assume 80% of people are insured, but it's going to be high in any case. That is for the children ( $3.30 a share )

Adults is another story, and I don't really know how crazy off label use will be. Could easily be same numbers as child.

I remember SI stating 40 %, with bioreactors 60% , and someone from the Botanix thread has reminded me that MSB basically don't have that much of a say on how much profit they keep, as the remaining 40% has to go towards manufacturing, pharmacy, insurers, etc.....

60% would be above average in the US industry for pharma. 70% I cannot imagine happening unless I hear it from Si's mouth.